A groundbreaking study introduces a novel nanoparticle therapy that holds promise for treating pancreatic cancer, a disease with a grim prognosis. The research, conducted by a multidisciplinary team, showcases the potential of magnetoelectric nanoparticles (MENPs) to shrink and eliminate pancreatic tumors in preclinical models, offering a minimally invasive approach to a highly lethal cancer. The study, published in the journal Advanced Science, was led by experts from Sylvester Comprehensive Cancer Center, the University of Miami College of Engineering, Moffitt Cancer Center, and Cellular Nanomed, Inc. The findings reveal that a single intravenous dose of MENPs, when activated by a magnetic field inside an MRI machine, can significantly reduce tumor size and extend survival rates without causing harm to healthy organs. This innovative therapy, which does not rely on drugs, heat, or invasive procedures, represents a significant advancement in cancer treatment, potentially overcoming the limitations of traditional methods like chemotherapy and surgery.
